TickerFactsScreenerDevelopers

Atara Biotherapeutics, Inc. (ATRA) — Operating Cash Flow

Annual figures by fiscal year, from SEC filings.

2016: -$60.02M2017: -$87.50M2018: -$179.77M2019: -$235.63M2020: -$180.76M2021: -$220.52M2022: -$270.43M2023: -$192.98M2024: -$68.72M2025: -$50.94M-$50.94M
2016Operating Cash Flow (USD)2025
Fiscal YearOperating Cash FlowChange YoY
2025-$50.94M+25.9%
2024-$68.72M+64.4%
2023-$192.98M+28.6%
2022-$270.43M-22.6%
2021-$220.52M-22.0%
2020-$180.76M+23.3%
2019-$235.63M-31.1%
2018-$179.77M-105.4%
2017-$87.50M-45.8%
2016-$60.02M—